BRIEF — Zealand Pharma Gets Positive CHMP Opinion For Zeydovio For Treatment Of Short Bowel Syndrome
Sept 18 (Reuters) — Zealand Pharma A/S: Zealand Pharma Receives Positive Chmp Opinion For Zeydovio™ (Glepaglutide) For The Treatment Of Short Bowel Syndrome Positive Chmp Opinion Marks First Major Advancement In Short Bowel Syndrome Treatment In Europe In More Than A Decade Source text:... Further company coverage: ZEL